Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.36% |
| 2 | Technology | 9.28% |
| 3 | Financials | 7.68% |
| 4 | Healthcare | 6.5% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
PUT
Gen Digital
GEN
$18.6B
| $5.68M | ﹤0.01% |
+200,000
| New | +$5.98M |
|
2902
PUT
Gartner
IT
$12.5B
| $5.68M | ﹤0.01% |
+21,600
| New | +$6.3M |
|
2903
Amylyx Pharmaceuticals
AMLX
$3.87B
| $5.68M | ﹤0.01% |
417,771
-1,094,287
| -72% | -$10.3M |
|
|
AAT
2904
American Assets Trust
AAT
$1.38B
| $5.67M | ﹤0.01% |
279,229
-293,300
| -51% | -$5.92M |
|
2905
Lightspeed Commerce
LSPD
$1.37B
| $5.67M | ﹤0.01% |
491,125
-409,620
| -45% | -$5.01M |
|
2906
LCI Industries
LCII
$2.5B
| $5.67M | ﹤0.01% |
60,860
+24,631
| +68% | +$2.46M |
|
|
SVCC
2907
Stellar V Capital Corp
SVCC
| $5.67M | ﹤0.01% |
550,000
| – | – |
|
|
MRSH
2908
CALL
Marsh
MRSH
$91.9B
| $5.66M | ﹤0.01% |
28,100
-50,400
| -64% | -$10.4M |
|
2909
National Beverage
FIZZ
$3.05B
| $5.66M | ﹤0.01% |
153,304
-264,610
| -63% | -$11.5M |
|
2910
CALL
Semtech
SMTC
$12.2B
| $5.66M | ﹤0.01% |
79,200
+53,000
| +202% | +$2.88M |
|
2911
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
| $5.65M | ﹤0.01% |
351,471
-1,060
| -0.3% | -$19.3K |
|
2912
City Holding Co
CHCO
$2.01B
| $5.65M | ﹤0.01% |
45,582
-7,146
| -14% | -$897K |
|
2913
iShares US Real Estate ETF
IYR
$4.58B
| $5.65M | ﹤0.01% |
58,154
-59,259
| -50% | -$5.7M |
|
2914
TransDigm Group
TDG
$65.6B
| $5.64M | ﹤0.01% |
4,280
-7,214
| -63% | -$10.3M |
|
2915
Harmony Biosciences
HRMY
$2.28B
| $5.64M | ﹤0.01% |
204,510
+175,221
| +598% | +$6.04M |
|
2916
CALL
Aon
AON
$75.4B
| $5.63M | ﹤0.01% |
15,800
-500
| -3% | -$181K |
|
2917
CALL
Pembina Pipeline
PBA
$27.9B
| $5.63M | ﹤0.01% |
100,000
| – | – |
|
2918
Ceco Environmental
CECO
$4.08B
| $5.62M | ﹤0.01% |
109,830
+4,990
| +5% | +$211K |
|
2919
CALL
Elevance Health
ELV
$85.5B
| $5.62M | ﹤0.01% |
17,400
-20,000
| -53% | -$6.22M |
|
2920
Solid Biosciences
SLDB
$1.05B
| $5.61M | ﹤0.01% |
909,701
-189,672
| -17% | -$1.11M |
|
|
ALX
2921
Alexander's
ALX
$1.38B
| $5.61M | ﹤0.01% |
23,935
+13,060
| +120% | +$3.07M |
|
2922
Kaspi.kz JSC
KSPI
$20.2B
| $5.61M | ﹤0.01% |
68,634
+37,230
| +119% | +$3.26M |
|
|
BLDP
2923
Ballard Power Systems
BLDP
$678M
| $5.6M | ﹤0.01% |
2,064,405
-472,644
| -19% | -$967K |
|
2924
PUT
Brighthouse Financial
BHF
$3.05B
| $5.6M | ﹤0.01% |
+105,500
| New | +$5.15M |
|
2925
Hovnanian Enterprises
HOV
$760M
| $5.59M | ﹤0.01% |
43,543
+7,525
| +21% | +$1M |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.